The short answer

For multiple sclerosis, cannabis is a symptom treatment, not a disease-modifying therapy. The strongest evidence covers spasticity and central neuropathic pain, with weaker support for sleep and bladder urgency. Nothing in the current literature suggests THC, CBD, or a combination changes relapse rates, lesion load, or long-term disability. If you are already on a DMT, cannabis does not replace it. If you are not on one, cannabis is not a substitute.

Why spasticity gets the most attention

Spasticity, the stiffness and involuntary tightness that comes from damaged upper motor neurons, responds to cannabinoids in a way that shows up in controlled trials. Nabiximols (Sativex), an oromucosal spray with roughly equal THC and CBD, is approved in Canada, the UK, and much of Europe as an add-on for MS spasticity that has not responded to other treatments. In trials it tends to improve patient-reported spasticity scores and reduce spasm frequency, though objective measures like walking speed often move less.

Nabiximols is not FDA-approved in the US. That leaves American patients with smoked or vaporized flower, oral THC products, tinctures, and edibles, none of which carry the same trial data behind them.

Pain, sleep, and bladder urgency

Neuropathic pain is the second area with real signals. Trials of oral THC and nabiximols show modest reductions in central pain, but the effect sizes are small and the studies are short. Sleep tends to improve alongside pain and spasticity rather than on its own, and it is hard to separate a genuine sleep effect from plain sedation.

Bladder symptoms have a thinner evidence base. Some patients report fewer urgency episodes, but the trials are small and the results inconsistent. Talk to a urologist before you treat urgency with cannabis, because retention is a real risk.

What cannabis does not do

Products you will actually see

Medical programs in the US sell a wide range, and the label rarely tells you how a product compares to what was studied in trials.

Side effects that hit MS patients harder

The side effect profile overlaps badly with existing MS symptoms. Dizziness, unsteadiness, cognitive fog, dry mouth, and drowsiness are common, and each one can make walking or thinking worse. THC can also raise heart rate and lower blood pressure, which matters if you have orthostatic intolerance.

Regular high-dose use carries a risk of cannabis use disorder, roughly 9 percent of users, and a small but real risk of cannabis hyperemesis syndrome. Smoking adds respiratory risk that has nothing to do with MS.

Interactions and precautions

The US legal reality

No cannabis product is FDA-approved for MS. States run medical programs in parallel, so legality, product testing, and possession limits vary by where you live. A dispensary recommendation is not the same thing as a treatment plan, and no one behind the counter should be managing your spasticity in place of your neurologist.

Questions worth asking your neurologist

Bring a symptom diary. Spasticity and pain are subjective, and a log is the only way to tell a real effect from a good week.